VILDIABATE PIO

VILDIABATE PIO combines two potent medications, Vildagliptin (50 mg) and Pioglitazone Hydrochloride (15 mg), to help manage type 2 diabetes mellitus. This combination therapy is designed to enhance glycemic control when diet and exercise alone are insufficient.

How Does It Work?

The combination of Vildagliptin and Pioglitazone works synergistically to control blood sugar levels:

• Vildagliptin: Inhibits the enzyme DPP-4, increasing incretin levels, which in turn boost insulin release and reduce glucagon levels in the blood.
• Pioglitazone: Improves insulin sensitivity by acting on peroxisome proliferator-activated receptor-gamma (PPAR-γ) in fat cells, muscle cells, and liver, enhancing glucose uptake and utilization.

Uses of Vildagliptin 50 mg & Pioglitazone Hydrochloride 15 mg

VILDIABATE PIO is used for:

• Managing type 2 diabetes mellitus.
• Improving glycemic control in adults.
• Complementing diet and exercise efforts in diabetes management.

What is Vildagliptin 50 mg & Pioglitazone Hydrochloride 15 mg?

This medication is a combination oral therapy specifically designed to address the complex needs of type 2 diabetes patients by combining the benefits of two distinct mechanisms of action to optimize blood sugar control.

Side Effects

Common side effects include:

• Upper respiratory tract infections
• Headache
• Edema (swelling)
• Hypoglycemia (especially when combined with other antidiabetics)
• Weight gain
• Muscle pain

Safety Information

When using VILDIABATE PIO, keep in mind:

• Regularly monitor liver function.
• Be cautious if you have a history of heart failure.
• Inform your doctor about all medications you're taking to avoid potential interactions.
• Not recommended for patients with severe heart failure or active bladder cancer.
• Watch for signs of hypoglycemia and manage accordingly.

If You Need More Information About  VILDIABATE PIO  Click here